Yuichi Kakudo

605 total citations
15 papers, 505 citations indexed

About

Yuichi Kakudo is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuichi Kakudo has authored 15 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuichi Kakudo's work include Cancer-related Molecular Pathways (6 papers), Curcumin's Biomedical Applications (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Yuichi Kakudo is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Curcumin's Biomedical Applications (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Yuichi Kakudo collaborates with scholars based in Japan and Canada. Yuichi Kakudo's co-authors include Chikashi Ishioka, Hiroyuki Shibata, Shunsuke Kato, Shin Takahashi, Yoshiharu Iwabuchi, Hiroyuki Yamakoshi, Hisatsugu Ohori, Takao Suzuki, Atsuko Takahashi and Satoshi Kato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Yuichi Kakudo

15 papers receiving 498 citations

Peers

Yuichi Kakudo

ONCOL

PRM

Ibrahim Al‐Jammaz Saudi Arabia

Xiaomei Jiang China

Nathan M. Weir United States

Chuanbing Shi China

Sara Bystrup Spain

Mayrel Palestino Domínguez Mexico

Sifeng Tao China

Vicenç Ruiz de Porras Spain

AmirReza Hesari Iran

Pihong Li China

Ibrahim Al‐Jammaz Saudi Arabia

Yuichi Kakudo

162 ×0.6

109 ×0.6

82 ×0.6

ONCOL

33 ×0.5

44 ×0.8

PRM

Citations per year, relative to Yuichi Kakudo Yuichi Kakudo (= 1×) peers Ibrahim Al‐Jammaz

Countries citing papers authored by Yuichi Kakudo

Since Specialization

Citations

This map shows the geographic impact of Yuichi Kakudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Kakudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Kakudo more than expected).

Fields of papers citing papers by Yuichi Kakudo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Kakudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Kakudo. The network helps show where Yuichi Kakudo may publish in the future.

Co-authorship network of co-authors of Yuichi Kakudo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Kakudo. A scholar is included among the top collaborators of Yuichi Kakudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Kakudo. Yuichi Kakudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Shimodaira, Hideki, Makio Gamoh, Hideaki Ando, et al.. (2014). Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on <b><i>KRAS</i></b> Mutation Status (T-CORE0801). Oncology. 87(1). 7–20. 16 indexed citations

Takahashi, Shin, Yuichi Kakudo, Masanobu Takahashi, et al.. (2014). Upper Arm Central Venous Port Implantation: A 6-Year Single Institutional Retrospective Analysis and Pictorial Essay of Procedures for Insertion. PLoS ONE. 9(3). e91335–e91335. 28 indexed citations

Nagai, Hiroki, Toshiyuki Kitano, Takafumi Nishimura, et al.. (2013). Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study. Supportive Care in Cancer. 21(12). 3271–3278. 7 indexed citations

Imai, Hiroo, Shunsuke Kato, Yasuhiro Sakamoto, et al.. (2013). High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H. Oncology Reports. 31(3). 1043–1050. 5 indexed citations

Ishii, Tadashi, et al.. (2013). [A multicenter trial of regional medical cooperation for cancer chemotherapy after the great East Japan earthquake].. PubMed. 40(3). 343–8. 3 indexed citations

Yasuda, Katsuhiro, Shunsuke Kato, Yasuhiro Sakamoto, et al.. (2012). Induction of apoptosis by cytoplasmically localized wild-type p53 and the S121F mutant super p53. Oncology Letters. 3(5). 978–982. 3 indexed citations

Takahashi, Masahiro, Yuichi Kakudo, Shin Takahashi, et al.. (2012). Overexpression of DRAM enhances p53‐dependent apoptosis. Cancer Medicine. 2(1). 1–10. 22 indexed citations

Yoshioka, Takashi, Shunsuke Kato, Makio Gamoh, et al.. (2009). Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer. British Journal of Cancer. 101(12). 1972–1977. 17 indexed citations

Shibata, Hiroyuki, Hiroyuki Yamakoshi, Atsuko Sato, et al.. (2009). Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo. Cancer Science. 100(5). 956–960. 55 indexed citations

10.

Otsuka, Kazunori, et al.. (2007). The screening of the second‐site suppressor mutations of the common p53 mutants. International Journal of Cancer. 121(3). 559–566. 22 indexed citations

11.

Shibata, Hiroyuki, Hiroshi Takano, Masaki Ito, et al.. (2007). α-Catenin is essential in intestinal adenoma formation. Proceedings of the National Academy of Sciences. 104(46). 18199–18204. 25 indexed citations

12.

Ohori, Hisatsugu, Hiroyuki Yamakoshi, Masaki Tomizawa, et al.. (2006). Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Molecular Cancer Therapeutics. 5(10). 2563–2571. 210 indexed citations

13.

Yoshioka, Takashi, Shunsuke Kato, Natsuko Chiba, et al.. (2006). Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation. International Journal of Clinical Oncology. 11(6). 454–460. 19 indexed citations

14.

Kakudo, Yuichi, Takashi Yoshioka, Masahito Hanada, et al.. (2006). [A case of malignant melanoma from the esophagus responding to weekly paclitaxel therapy].. PubMed. 33(7). 969–72. 1 indexed citations

15.

Kakudo, Yuichi, Hiroyuki Shibata, Kazunori Otsuka, Shunsuke Kato, & Chikashi Ishioka. (2005). Lack of Correlation between p53-Dependent Transcriptional Activity and the Ability to Induce Apoptosis among 179 Mutant p53s. Cancer Research. 65(6). 2108–2114. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact